These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


372 related items for PubMed ID: 22820867

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants.
    Richardson-Jones JW, Craige CP, Guiard BP, Stephen A, Metzger KL, Kung HF, Gardier AM, Dranovsky A, David DJ, Beck SG, Hen R, Leonardo ED.
    Neuron; 2010 Jan 14; 65(1):40-52. PubMed ID: 20152112
    [Abstract] [Full Text] [Related]

  • 23. Glucocorticoid receptor-dependent desensitization of 5-HT1A autoreceptors by sleep deprivation: studies in GR-i transgenic mice.
    Evrard A, Barden N, Hamon M, Adrien J.
    Sleep; 2006 Jan 14; 29(1):31-6. PubMed ID: 16453979
    [Abstract] [Full Text] [Related]

  • 24. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
    Zhang H, Wang W, Jiang Z, Shang J, Zhang L.
    Arzneimittelforschung; 2010 Jan 14; 60(3):109-15. PubMed ID: 20422941
    [Abstract] [Full Text] [Related]

  • 25. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.
    Bortolozzi A, Díaz-Mataix L, Toth M, Celada P, Artigas F.
    Psychopharmacology (Berl); 2007 Apr 14; 191(3):745-58. PubMed ID: 17265076
    [Abstract] [Full Text] [Related]

  • 26. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus.
    Bermack JE, Haddjeri N, Debonnel G.
    J Pharmacol Exp Ther; 2004 Aug 14; 310(2):578-83. PubMed ID: 15044555
    [Abstract] [Full Text] [Related]

  • 27. Sustained pharmacological blockade of NK1 substance P receptors causes functional desensitization of dorsal raphe 5-HT 1A autoreceptors in mice.
    Guiard BP, Froger N, Hamon M, Gardier AM, Lanfumey L.
    J Neurochem; 2005 Dec 14; 95(6):1713-23. PubMed ID: 16219031
    [Abstract] [Full Text] [Related]

  • 28. Electrophysiological evidence for rapid 5-HT₁A autoreceptor inhibition by vilazodone, a 5-HT₁A receptor partial agonist and 5-HT reuptake inhibitor.
    Ashby CR, Kehne JH, Bartoszyk GD, Renda MJ, Athanasiou M, Pierz KA, Seyfried CA.
    Eur J Pharmacol; 2013 Aug 15; 714(1-3):359-65. PubMed ID: 23872377
    [Abstract] [Full Text] [Related]

  • 29. Glucocorticoid receptor antagonists hasten and augment neurochemical responses to a selective serotonin reuptake inhibitor antidepressant.
    Johnson DA, Grant EJ, Ingram CD, Gartside SE.
    Biol Psychiatry; 2007 Dec 01; 62(11):1228-35. PubMed ID: 17651703
    [Abstract] [Full Text] [Related]

  • 30. Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B.
    Hughes ZA, Starr KR, Scott CM, Newson MJ, Sharp T, Watson JM, Hagan JJ, Dawson LA.
    Psychopharmacology (Berl); 2007 May 01; 192(1):121-33. PubMed ID: 17265079
    [Abstract] [Full Text] [Related]

  • 31. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors.
    Zhang J, Huang XY, Ye ML, Luo CX, Wu HY, Hu Y, Zhou QG, Wu DL, Zhu LJ, Zhu DY.
    J Neurosci; 2010 Feb 17; 30(7):2433-41. PubMed ID: 20164327
    [Abstract] [Full Text] [Related]

  • 32. A chronic treatment with fluoxetine decreases 5-HT(1A) receptors labeling in mice selected as a genetic model of helplessness.
    Naudon L, El Yacoubi M, Vaugeois JM, Leroux-Nicollet I, Costentin J.
    Brain Res; 2002 May 17; 936(1-2):68-75. PubMed ID: 11988231
    [Abstract] [Full Text] [Related]

  • 33. Increased serotonin-1A (5-HT1A) autoreceptor expression and reduced raphe serotonin levels in deformed epidermal autoregulatory factor-1 (Deaf-1) gene knock-out mice.
    Czesak M, Le François B, Millar AM, Deria M, Daigle M, Visvader JE, Anisman H, Albert PR.
    J Biol Chem; 2012 Feb 24; 287(9):6615-27. PubMed ID: 22232550
    [Abstract] [Full Text] [Related]

  • 34. Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment.
    Scorza MC, Lladó-Pelfort L, Oller S, Cortés R, Puigdemont D, Portella MJ, Pérez-Egea R, Alvarez E, Celada P, Pérez V, Artigas F.
    Br J Pharmacol; 2012 Nov 24; 167(5):1021-34. PubMed ID: 22050051
    [Abstract] [Full Text] [Related]

  • 35. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM, Monge A, Del Río J, Lasheras B.
    Eur J Pharmacol; 2002 May 03; 442(1-2):63-71. PubMed ID: 12020683
    [Abstract] [Full Text] [Related]

  • 36. Effects of standardized extracts of St. John's wort on the single-unit activity of serotonergic dorsal Raphe neurons in awake cats: comparisons with fluoxetine and sertraline.
    Fornal CA, Metzler CW, Mirescu C, Stein SK, Jacobs BL.
    Neuropsychopharmacology; 2001 Dec 03; 25(6):858-70. PubMed ID: 11750179
    [Abstract] [Full Text] [Related]

  • 37. Serotonin-1A receptor function in the dorsal raphe nucleus following chronic administration of the selective serotonin reuptake inhibitor sertraline.
    Rossi DV, Burke TF, McCasland M, Hensler JG.
    J Neurochem; 2008 May 03; 105(4):1091-9. PubMed ID: 18182050
    [Abstract] [Full Text] [Related]

  • 38. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine.
    Li XM, Perry KW, Wong DT.
    Chin J Physiol; 1999 Jun 30; 42(2):53-9. PubMed ID: 10513599
    [Abstract] [Full Text] [Related]

  • 39. RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis.
    Ferrés-Coy A, Pilar-Cuellar F, Vidal R, Paz V, Masana M, Cortés R, Carmona MC, Campa L, Pazos A, Montefeltro A, Valdizán EM, Artigas F, Bortolozzi A.
    Transl Psychiatry; 2013 Jan 15; 3(1):e211. PubMed ID: 23321808
    [Abstract] [Full Text] [Related]

  • 40. Chronic fluoxetine-induced desensitization of 5-HT1A and 5-HT1B autoreceptors: regional differences and effects of WAY-100635.
    Newman ME, Shalom G, Ran A, Gur E, Van de Kar LD.
    Eur J Pharmacol; 2004 Feb 13; 486(1):25-30. PubMed ID: 14751404
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.